申请人:Hogenkamp Derk J.
公开号:US20080064748A1
公开(公告)日:2008-03-13
The invention relates to substituted enaminones of Formula I and their derivatives and the discovery that these compounds modulate the effect of γ-aminobutyric acid (GABA) on the GABA
A
receptor complex in a therapeutically relevant fashion and may be used to ameliorate CNS disorders amenable to modulation of the GABA
A
receptor complex.
本发明涉及式I的取代烯
氨酮及其衍
生物,以及发现这些化合物以治疗相关的方式调节γ-
氨基
丁酸(
GABA)对
GABAA受体复合物的作用,并可用于改善可通过调节
GABAA受体复合物来治疗的中枢神经系统疾病。